Makutiro Masavuli

Adelaide Medical School

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Makutiro is a postdoctoral researcher currently working in the Viral Immunology Group developing safe and effective vaccines against Hepatitis C (HCV), human immunodeficiency virus (HIV), Zika virus and more recently against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Career
Publications
Supervision
Contact

Appointments

Date Position Institution name

2019 - ongoing Postdoctoral Researcher The University of Adelaide

Date	Position	Institution name
2019 - ongoing	Postdoctoral Researcher	The University of Adelaide

Language Competencies

Language	Competency
English	Can read, write, speak, understand spoken and peer review
French	Can read, write, speak, understand spoken and peer review
Swahili	Can read, write, speak, understand spoken and peer review

Education

Date Institution name Country Title

2018 University of Adelaide, Adelaide Australia PhD
Research Interests

Infectious Diseases Vaccinology

Date	Institution name	Country	Title
2018	University of Adelaide, Adelaide	Australia	PhD

Journals

Year	Citation
2025	Perkins, G. B., Tunbridge, M. J., Chai, C. S., Hope, C. M., Yeow, A. E. L., Salehi, T., . . . Toby Coates, P. (2025). mTOR Inhibitors and Vaccine Response in Kidney Transplant Recipients. Journal of the American Society of Nephrology. DOI
2023	Ryan, F. J., Norton, T. S., McCafferty, C., Blake, S. J., Stevens, N. E., James, J., . . . Lynn, D. J. (2023). A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines.. Cell Reports Medicine, 4(3), 100971-1-100971-26. DOI Scopus30 WoS1 Europe PMC25
2023	Williams, C. M. D., Noll, J. E., Bradey, A. L., Duggan, J., Wilczek, V. J., Masavuli, M. G., . . . Panagopoulos, V. (2023). Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma. British Journal of Haematology, 203(4), 614-624. DOI Scopus2 Europe PMC3
2023	Wijesundara, D. K., Yeow, A., McMillan, C. L. D., Choo, J. J. Y., Todorovic, A., Mekonnen, Z. A., . . . Muller, D. A. (2023). Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine. Molecular Therapy Nucleic Acids, 34, 102056-1-102056-10. DOI Scopus5 Europe PMC2
2022	Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Yeow, A. E. L., . . . Lynn, D. J. (2022). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Medicine, 20(1), 26-1-26-23. DOI Scopus188 WoS91 Europe PMC169
2022	Perkins, G. B., Tunbridge, M., Salehi, T., Chai, C. S., Kireta, S., Johnston, J., . . . Coates, P. T. (2022). Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19. Kidney International, 101(5), 1077-1080. DOI Scopus10 WoS5 Europe PMC6
2022	Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk., B. (2022). SARS-CoV-2 Omicron variant escapes neutralising antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents.. Cell Reports Medicine, 3(6), 23 pages. DOI Scopus32 WoS15 Europe PMC28
2022	Ryan, F. J., Norton, T. S., McCafferty, C., Blake, S. J., Stevens, N. E., James, J., . . . Lynn, D. J. (2022). A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA (BNT162b2/mRNA-1273) and adenovirus vectored vaccines (ChAdOx1-S) after the first, second and third doses. DOI
2021	Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Lip Yeow, A. E., . . . Lynn, D. J. (2021). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. DOI Europe PMC1
2021	Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk, B. (2021). COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection. DOI
2020	Gummow, J., Masavuli, M., Mekonnen, Z. A., Li, Y., Wijesundara, D. K., Shrestha, A. C., . . . Grubor-Bauk, B. (2020). Safety profile of a multi-antigenic DNA vaccine against hepatitis C virus. Vaccines, 8(1), 1-15. DOI Scopus9 WoS4 Europe PMC5
2020	Mekonnen, Z. A., Masavuli, M. G., Yu, W., Gummow, J., Whelan, D. M., Al-Delfi, Z., . . . Grubor-Bauk, B. (2020). Enhanced T cell responses induced by a necrotic dendritic cell vaccine, expressing HCV NS3. Front Microbiol, 11, 1-13. DOI Scopus7 WoS3 Europe PMC3
2019	Mekonnen, Z. A., Grubor-Bauk, B., Masavuli, M. G., Shrestha, A. C., Ranasinghe, C., Bull, R. A., . . . Wijesundara, D. K. (2019). Toward DNA-based T-cell mediated vaccines to target HIV-1 and hepatitis C virus: approaches to elicit localized immunity for protection. Frontiers in Cellular and Infection Microbiology, 9(APR), 1-8. DOI Scopus14 WoS7 Europe PMC8
2019	Shrestha, A. C., Wijesundara, D. K., Masavuli, M. G., Mekonnen, Z. A., Gowans, E. J., & Grubor-Bauk, B. (2019). Cytolytic perforin as an adjuvant to enhance the immunogenicity of DNA vaccines. Vaccines, 7(2), 14 pages. DOI Scopus11 WoS11 Europe PMC9
2019	Masavuli, M. G., Wijesundara, D. K., Underwood, A., Christiansen, D., Earnest-Silveira, L., Bull, R., . . . Grubor-Bauk, B. (2019). A hepatitis C virus DNA vaccine encoding a secreted, oligomerized form of envelope proteins is highly immunogenic and elicits neutralizing antibodies in vaccinated mice. Frontiers in immunology, 10(MAY), 1-19. DOI Scopus32 WoS24 Europe PMC23
2019	Mekonnen, Z. A., Grubor-Bauk, B., English, K., Leung, P., Masavuli, M. G., Shrestha, A. C., . . . Wijesundara, D. K. (2019). Single-dose vaccination with a hepatotropic adeno-associated virus efficiently localizes T cell immunity in the liver with the potential to confer rapid protection against Hepatitis C virus. Journal of Virology, 93(19), e00202-19-1-e00202-19-19. DOI Scopus12 WoS8 Europe PMC12
2019	Grubor-Bauk, B., Wijesundara, D. K., Masavuli, M., Abbink, P., Peterson, R. L., Prow, N. A., . . . Gowans, E. J. (2019). NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice.. Sci Adv, 5(12), eaax2388. DOI Scopus60 WoS36 Europe PMC45
2017	Masavuli, M., Wijesundara, D., Torresi, J., Gowans, E., & Grubor-Bauk, B. (2017). Preclinical development and production of virus-like particles as vaccine candidates for hepatitis C. Frontiers in Microbiology, 8(DEC), 11 pages. DOI Scopus37 WoS19 Europe PMC24

Conference Items

Year	Citation
2017	Masavuli, M. G., Wijesundara, D. K., Grubor-Bauk, B., & Gowans, E. J. (2017). Novel DNA vaccine formulations encoding secreted HCV-E1/E2 fused to the IMX313 oligomerisation domain are immunogenic in mice. Poster session presented at the meeting of 12th Annual Scientific Meeting of the Australian Centre for HIV and Hepatitis Virology.
2017	Masavuli, M. G., Wijesundara, D. K., Grubor-Bauk, B., & Gowans, E. J. (2017). Novel DNA vaccine formulations encoding secreted HCV-E1/E2 fused to the IMX313 oligomerisation domain are immunogenic in mice. Poster session presented at the meeting of Adelaide Immunology Retreat. Nuriootpa.
2017	Masavuli, M. G., Wijesundara, D. K., Grubor-Bauk, B., & Gowans, E. J. (2017). Novel DNA vaccine formulations encoding secreted HCV-E1/E2 fused to the IMX313 oligomerisation domain are immunogenic in mice. Poster session presented at the meeting of Florey Postgraduate Research Conference.
2017	Masavuli, M. G., Wijesundara, D. K., Grubor-Bauk, B., & Gowans, E. J. (2017). Enhancing the immunogenicity of HCV vaccines by fusing E1/E2 to the IMX313P multimerization technology. Poster session presented at the meeting of 24th International Symposium on Hepatitis C Virus and Related Viruses. Hyannis, Cape Cod, Massachusetts, USA.
2017	Masavuli, M. G., Wijesundara, D. K., Grubor-Bauk, B., & Gowans, E. J. (2017). Novel DNA vaccines encoding secreted HCV-E1/E2 fused to the IMX313 oligomerisation domain are immunogenic in mice. Poster session presented at the meeting of The Queen Elizabeth Hospital (TQEH) Research Day. Adeleide, Australia.
2017	Masavuli, M. G., Wijesundara, D. K., Grubor-Bauk, B., & Gowans, E. J. (2017). Enhancing the immunogenicity of HCV vaccines by fusing E1/E2 to the IMX313P oligomerisation technology. Poster session presented at the meeting of 9th Australasian Virology Society Meeting.
2016	Masavuli, M. G., Wijesundara, D. K., Grubor-Bauk, B., & Gowans, E. J. (2016). A novel DNA-based virus-like particle (VLP) vaccine against hepatitis C.. Poster session presented at the meeting of Florey Postgraduate Research Conference.
2016	Masavuli, M. G., Wijesundara, D. W., Grubor-Bauk, B., & Gowans, E. J. (2016). A DNA-based virus-like particle (VLP) vaccine against the hepatitis C virus. Poster session presented at the meeting of The Queen Elizabeth Hospital (TQEH) Research Day. Adelaide.
2015	Masavuli, M. G., Grubor-Bauk, B. G., Wijesundara, D. K., & Gowans, E. J. (2015). A novel DNA-based virus-like particle (VLP) vaccine for hepatitis C virus. Poster session presented at the meeting of Florey Postgraduate Research Conference. AdelaIide.
2015	Masavuli, M. G., Wijesundara, D. K., grubor-bauk, B., & gowans, E. G. (2015). A novel DNA-based virus-like particle vaccine for hepatitis C virus. Poster session presented at the meeting of The Queen Elizabeth Hospital (TQEH) Research Day 2015. Adelaide.

Theses

Year	Citation
2018	Masavuli, M. G. (2018). Novel DNA Vaccine Formulations Against Hepatitis C Virus. (PhD Thesis).
2013	Masavuli, M. G. (2013). Characterisation of leukocytes from IL-5 transgenic mice during Nippostrongylus brasiliensis infection.. (Undergraduate Dissertation).

Current Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2024	Co-Supervisor	Harnessing the potential of mRNA vaccines against Hepatitis C Virus	Doctor of Philosophy	Doctorate	Full Time	Mr John Henrik Johansson
2022	Co-Supervisor	A Trivalent Vaccine for Clinically-Important Flaviviruses.	Doctor of Philosophy	Doctorate	Full Time	Mr Ryan Santos
2021	Co-Supervisor	The development of 'next generation' DNA-based vaccine against SARS-CoV-2	Doctor of Philosophy	Doctorate	Full Time	Miss Zahraa Nima Saeed Al-Delfi

Email: makutiro.masavuli@adelaide.edu.au

Makutiro Masavuli

Appointments

Language Competencies

Education

Research Interests

Journals

Conference Items

Theses

Current Higher Degree by Research Supervision (University of Adelaide)

Connect With Me

External Profiles